Medical Imaging Markets: Contrast Agents (X-Ray, CT, Ultrasound, MRI, PET, SPECT)

Jul 9, 2012
Pages - Pub ID: KLI3953404
Abstract Table of Contents Search Inside Report Related Reports

Today’s capabilities in clinical diagnostic radiology have been made possible by advances not only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it possible to see, in great detail, the body’s internal structures, organs and tissue that would nototherwise be clearly seen. Although bones are readily apparent on radiographic images, other organs and tissues are not. These imaging agents may be usedduring a medical imaging procedure to highlight specific parts of the body andmake them easier to visualize.  The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise.   Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.

Generally, the market for contrast agents and radiopharmaceuticals is expected to sustain decent growth in the next fewyears, with much of that growth coming from the MRI, ultrasound and nuclear medicine modalities. While equipment manufacturers may have experienced a slumpin sales due to the recent recession, there is still a need for these agents,as well as for radiopharmaceuticals, to help image, track and diagnose disease, especially in the elderly. Even though hospitals and clinics may have slowed their equipment purchases because of the need to contain costs, procedures run on installed systems still require the use of contrast agents and radiopharmaceuticals.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama's medical imaging market reports. Coverage includes:

  • World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2016. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)
  • Market share of the major contrast agent supplers
  • Procedure volumes by modality and region
  • Estimates of the portion of procedures in each modality using contrast enhancement
  • Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging’s role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer’s, and other indications are also reviewed.

The report concludes with profiles of top suppliers and developers including:

  • Acusphere Inc.
  • Alseres Pharmaceuticals Inc.
  • Amag Pharmaceuticals Inc.
  • Aposense Ltd.
  • Avid Radiopharmaceuticals Inc.
  • Bayer Schering Pharma
  • Bracco SpA
  • Cell Point
  • Covidien Ltd.
  • Daiichi Pharmaceutical Co. Ltd.
  • Dendritic NanoTechnologies Inc.
  • Draximage
  • Endocyte Inc.
  • Eusa Pharma
  • GE Healthcare
  • Guerbet Group
  • Hovione FarmaCiencia SA
  • Imcor Pharmaceutical Co.
  • Immunomedics Inc.
  • Insight Agents GmbH
  • King Pharmaceuticals Inc.
  • Luna nanoWorks
  • Macrocyclics
  • MDS Nordion
  • NanoScan Imaging
  • Palatin Technologies Inc.
  • Pharmacyclics
  • Point Biomedical Corp.
  • Starpharma Holdings Ltd.
  • VisEn Medical Inc.

Related Reports:

The Global Market for Medical Devices, 5th Edition
May 28, 2014 - KLI5254463 - $2,500.00

Medical Device Markets in The Middle East
May 14, 2014 - KLI5241892 - $995.00

Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others)
Feb 5, 2014 - KLI5199102 - $3,995.00

The World Market for Cardiovascular Diagnostics (Markets for ECG, Imaging, Cardiac POC, Contrast Agents and Cardiac Markers)
Jun 25, 2013 - KLI5068892 - $3,995.00

Medical Imaging Markets Market Research Bundle (X-Ray, Digital X-Ray, CT, SPECT, MRI, Ultrasound, Contrast Agents, Molecular Imaging)
Feb 5, 2013 - KLI4960453 - $4,995.00

Bundle: Medical Imaging Markets and Medical Contrast Agent Markets Global License
Sep 27, 2012 - KLI4880444 - $12,784.00

Medical Imaging Markets: Molecular Imaging
Sep 26, 2012 - KLI4880679 - $3,995.00

Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets
Mar 1, 2012 - KLI6654381 - $3,500.00

Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
Nov 1, 2011 - KLI6404203 - $3,500.00

Image-Guided Surgery (X-Ray, CT, PET, MRI and Ultrasound in Brain Surgery, Spinal Surgery and Other Applications)
Aug 1, 2011 - KLI6232446 - $2,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition
Results of The 2012 Kalorama IVD Procedure Count: White Paper
The World Market for Point of Care (POC) Diagnostics
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
Why Epigenomics May Be a Game-Changer in Diagnostics and Pharmaceuticals
IVD Procedure Volume and Pricing Analysis
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Home About Us My Account Personal Library Contact Us
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
7/25/2014 - 41
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST